Biomedical papers, 2016 (vol. 160), issue 1

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016, 160(1):39-53 | 10.5507/bp.2015.065

Quantification of selected antidepressants and antipsychotics in clinical samples using chromatographic methods combined with mass spectrometry: A review (2006-2015)

Pavel Sistika, Miroslav Turjapb, Andreea Maria Iordachea, Helena M.E.B. Saldanhaa, Karel Lemra, Petr Bednara
a Regional Centre of Advanced Technologies and Materials, Department of Analytical Chemistry, Faculty of Science, Palacky University Olomouc, Czech Republic
b Department of Pharmacology and CEITEC, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Background: Psychiatric disorders contribute significantly to worldwide morbidity and mortality. In the case of depression and schizophrenia, effective drug therapy is available but 30-50% of patients do not respond sufficiently to the initial treatment regimen. Apart from the development of new molecules, it is desirable to optimize treatment outcomes with agents that are currently available. Therapeutic drug monitoring (TDM) is a suitable and widely accepted approach for improving the efficacy and safety of these drugs.

Methods: A review of the relevant literature published between 2006 and January 2015.

Results and Conclusions: This review describes major advances and drawbacks in the field of chromatography coupled with single or tandem mass spectrometry (LC-MS, LC-MS/MS and GC/MS) of selected antidepressants (agomelatine, vilazodone) and antipsychotics (iloperidone, asenapine, amisulpride, aripiprazole, melperone, zotepine, ziprasidone). The high specificity in combination with high sensitivity makes these techniques an attractive complementary method to traditional procedures used in routine practice for TDM.

Keywords: antidepressant, antipsychotic, drug, chromatography, mass spectrometry, sample preparation, matrix effect

Received: April 30, 2015; Accepted: December 4, 2015; Prepublished online: January 12, 2016; Published: March 30, 2016


Attachments:

Download fileBiomed160-1-039-053-Supp.pdf

Size303.25 kB

References

  1. Hidaka BH, Depression as a disease of modernity: explanations of increasing prevalence. J Affect Disord 2012;140(3):205-14. Go to original source... Go to PubMed...
  2. Mercier A, Auger-Aubin I, Lebeau JP, Schuers M, Boulet P, Van Royen P, Peremans L. Why do general practitioners prescribe antidepressants to their patients? A pilot study. Biopsychosoc Med 2014;8:17-25. Go to original source... Go to PubMed...
  3. Smyth WF, Rodriguez V. Recent studies of the electrospray ionisation behaviour of selected drugs and their application in capillary electrophoresis-mass spectrometry and liquid chromatography-mass spectrometry. J Chromatogr A 2007;1159(1-2):159-74. Go to original source... Go to PubMed...
  4. Patteet L, Cappelle D, Maudens KE, Crunelle CL, Sabbe B, Neels H. Advances in detection of antipsychotics in biological matrices. Clin Chim Acta 2015;441(0):11-22. Go to original source... Go to PubMed...
  5. Saar E, Beyer J, Gerostamoulos D, Drummer OH. The analysis of antipsychotic drugs in human matrices using LC-MS(/MS). Drug Test Anal 2012;4(6):376-94. Go to original source... Go to PubMed...
  6. Zhang G, Jr AVT, Bartlett MG. Bioanalytical methods for the determination of antipsychotic drugs. Biomed Chromatogr 2008;22(7):671-87. Go to original source... Go to PubMed...
  7. Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Grunder G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Muller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry 2011;44(6):195-235.
  8. MacKichan JJ. Interpretation of serum drug concentrations. In: Lee M, editor. Basic Skills in Interpreting Laboratory Data. 5 ed. Bethesda: American Society of Health-System Pharmacists; 2013,p.71-117.
  9. Ensom MHH, Davis GA, Cropp CD, Ensom RJ. Clinical pharmacokinetics in the 21st century - Does the evidence support definitive outcomes? Clin Pharmacokinet 1998;34(4):265-79. Go to original source... Go to PubMed...
  10. European Medicines Agency. Assessment Report- Agomelatine: European Medicines Agency; 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000915/WC500046226.pdf.
  11. The ECNP Taskforce on Nomenclature. Neuroscience-based Nomenclature; 2015. Available from: https://www.ecnp.eu/projects-initiatives/nomenclature.aspx.
  12. Stahl SM. Prescriber's Guide: Stahl's Essential Psychopharmacology. 5 ed. New York: Cambridge University Press; 2014.
  13. Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4 ed. New York: Cambridge University Press; 2013.
  14. European Medicines Agency. Assessment report- Asenapine: European Medicines Agency; 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001177/WC500096898.pdf.
  15. Sumiyoshi T, Jayathilake K, Meltzer HY. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia. Schizophrenia Research 2003;62(1-2):65-72. Go to original source... Go to PubMed...
  16. Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 2000;68(1):29-39. Go to original source... Go to PubMed...
  17. SPC BURONIL 25 MG [2015 Jul 14]. Available from: http://www.sukl.cz/modules/medication/search.php.
  18. Lexicomp Online (Lexi-Drugs Online): Lexi-Comp, Inc., Hudson, Ohio; [cited 2015 2015 Jul 7]. Available from: http://online.lexi.com/ (login and subscription required).
  19. SPC ZOLEPTIL 50 [2015 Jul 14]. Available from: http://www.sukl.cz/modules/medication/search.php.
  20. Baranowska I, Magiera S, Baranowski J. Clinical applications of fast liquid chromatography: A review on the analysis of cardiovascular drugs and their metabolites. J Chromatogr B 2013;927:54-79. Go to original source...
  21. Mullett WM. Determination of drugs in biological fluids by direct injection of samples for liquid-chromatographic analysis. J Biochem Biophys Met 2007;70(2):263-73. Go to original source... Go to PubMed...
  22. Prabu SL, Suriyaprakash TNK. Extraction of Drug from the Biological Matrix: A Review. Applied Biological Engineering - Principles and Practice: InTech; 2012.
  23. Korfmacher WA. Using mass spectrometry for drug metabolism studies: CRC Press; 2005.
  24. Uřinovská R, Turjap M, Brozmanová H, Grundmann M. Analytical methods for the determination of selected psychopharmaceticals. Ceska Slov Farm 2010;59:103-11.
  25. Nakashima K. High-performance liquid chromatographic analysis of drugs of abuse in biologic samples. J Health Sci 2005;51(3):272-7. Go to original source...
  26. Berm EJJ, Paardekooper J, Brummel-Mulder E, Hak E, Wilffert B, Maring JG. A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS. Talanta 2015;134(0):165-72. Go to original source... Go to PubMed...
  27. Patteet L, Maudens KE, Stove CP, Lambert WE, Morrens M, Sabbe B, Neels H. The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography - tandem mass spectrometry. Drug Test Anal 2015;7(6):502-11. doi: 10.1002/dta.1698. Go to original source... Go to PubMed...
  28. Al-Dirbashi OY, Aboul-Enein HY, Al-Odaib A, Jacob M, Rashed MS. Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma. Biomed Chromatogr 2006;20(4):365-8. Go to original source... Go to PubMed...
  29. Gschwend MH, Arnold P, Ring J, Martin W. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. J Chromatogr B 2006;831(1-2):132-9. Go to original source...
  30. Aravagiri M, Marder SR, Pollock B. Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients. J Chromatogr B 2007;847(2):237-44. Go to original source...
  31. Zhang G, Terry AV, Jr., Bartlett MG. Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2008;22(7):770-8. Go to original source... Go to PubMed...
  32. Bhaumik U, Ghosh A, Sarkar AK, Bose A, Selvan PS, Sengupta P, Chakraborty US, Ghosh D, PalTK. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study. J Pharm Biomed Anal 2008;48(5):1404-10. Go to original source... Go to PubMed...
  33. Dasandi B, Shah S, Shivprakash. Development and validation of a high throughput and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of diltiazem and its two metabolites in human plasma: Application to a bioequivalence study. J Chromatogr B 2009;877(8-9):791-8. Go to original source...
  34. Lin SN, Lamm L, Newton TF, Reid MS, Moody DE, Foltz RL. A Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Method for Quantitation of Aripiprazole in Human Plasma. J Anal Toxicol 2009;33(5):237-42. Go to original source... Go to PubMed...
  35. Nozaki K, Osaka I, Kawasaki H, Arakawa R. Application of on-line electrochemistry/electrospray/tandem mass spectrometry to a quantification method for the antipsychotic drug zotepine in human serum. Anal Sci 2009;25(10):1197-201. Go to original source... Go to PubMed...
  36. Lei YQ, Zhang WY, Li HD, Yan MA, Zhu RH. Determination of Ziprasidone by UPLC-MS-MS and Its Application to a Pharmacokinetic Study of Chinese Schizophrenics. Chromatographia 2010;72(9-10):975-9. Go to original source...
  37. Chae YJ, Koo TS, Lee KR. A Sensitive and Selective LC-MS Method for the Determination of Lurasidone in Rat Plasma, Bile, and Urine. Chromatographia 2012;75(19-20):1117-28. Go to original source...
  38. Patil SR, Nerurkar KK, Kalamkar AM, Pukale V, Mangaonkar KV, Pingale SG. Validated LC-MS/MS method for quantification of agomelatine in human plasma and its application in a pharmacokinetic study. J Mass Spectrom 2012;47(1):23-8. Go to original source... Go to PubMed...
  39. Jamalapuram S, Vuppala PK, Mesangeau C, McCurdy CR, Avery BA. Determination of a highly selective mixed-affinity sigma receptor ligand, in rat plasma by ultra performance liquid chromatography mass spectrometry and its application to a pharmacokinetic study. J Chromatogr B 2012;891-892:1-6.
  40. Liang F, Terry AV, Bartlett MG. Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Biomed Chromatogr 2012;26(11):1325-32. Go to original source... Go to PubMed...
  41. Patel DP, Sharma P, Sanyal M, Shrivastav PS. SPE-UPLC-MS/MS method for sensitive and rapid determination of aripiprazole in human plasma to support a bioequivalence study. J Chromatogr B 2013;925:20-5. Go to original source...
  42. Zeng L-l, Sun L-l, Zou Q, Zhou F, Wei P, Ouyang P-k. Bioavailability comparison of a new form of vilazodone XVII to IV in beagles using liquid chromatography/mass spectrometry. Biomed Chromatogr 2014;28(12):1738-43. Go to original source... Go to PubMed...
  43. Wang XL, Zhang D, Liu M, Zhao HN, Du AH, Meng LJ, Liu HC. LC-MS/MS method for the determination of agomelatine in human plasma and its application to a pharmacokinetic study. Biomed Chromatogr 2014;28(2):218-22. Go to original source... Go to PubMed...
  44. Sui WW, Yang XJ, Yu WH, Jin Y, Luan XY, Wang XJ, Xu HY. A validated LC-MS/MS method for the rapid quantification of vilazodone in rat plasma: Application to a pharmacokinetic study. J Pharm Biomed Anal 2014;98:228-34. Go to original source... Go to PubMed...
  45. Zhang G, Terry AV, Bartlett MG. Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone,, clozapine, haloperidol and ziprasidone in rat brain tissue. J Chromatogr B 2007;858(1-2):276-81. Go to original source...
  46. Zhang G, Terry AV, Jr., Bartlett MG. Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat plasma. Rapid Commun Mass Spectrom 2007;21(6):920-8. Go to original source... Go to PubMed...
  47. Li KY, Zhou YG, Ren HY, Wang F, Zhang BK, Li HD. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples. J Chromatogr B 2007;850(1-2):581-5. Go to original source...
  48. Song M, Xu X, Hang T, Wen A, Yang L. Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma. Anal Biochem 2009;385(2):270-7. Go to original source... Go to PubMed...
  49. de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H. Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine. Biomed Chromatogr 2012;26(12):1461-3. Go to original source... Go to PubMed...
  50. Caloro M, Lionetto L, Cuomo I, Simonetti A, Pucci D, De Persis S, Casolla B, Kotzalidis GD, Sciarretta A, De Filippis S, Simmaco M, Girardi P. An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite. J Pharm Biomed Anal 2012;62:135-9. Go to original source... Go to PubMed...
  51. de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H. Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects. Biomed Chromatogr 2012;26(2):156-65. Go to original source... Go to PubMed...
  52. Ambavaram VB, Nandigam V, Vemula M, Kalluru GR, Gajulapalle M. Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of urapidil and aripiprazole in human plasma and its application to human pharmacokinetic study. Biomed Chromatogr 2013;27(7):916-23. Go to original source... Go to PubMed...
  53. Jia MM, Li J, He XM, Liu MZ, Zhou Y, Fan Y, Li WY. Simultaneous determination of iloperidone and its two active metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study. J Chromatogr B 2013;928:52-7. Go to original source...
  54. Reddy AVB, Venugopal N, Madhavi G. Simultaneous determination of asenapine and valproic acid in human plasma using LC-MS/MS: Application of the method to support pharmacokinetic study. J Pharm Anal 2013;3(6):394-401. Go to original source...
  55. Viette V, Guillarme D, Mylonas R, Mauron Y, Fathi M, Rudaz S, Hochstrasser D, Veuthey JL. A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part I). Clin Biochem 2011;44(1):32-44. Go to original source... Go to PubMed...
  56. Di Rago M, Saar E, Rodda LN, Turfus S, Kotsos A, Gerostamoulos D, Drummer OH. Fast targeted analysis of 132 acidic and neutral drugs and poisons in whole blood using LC-MS/MS. Forensic Sci Int 2014;243(0):35-43. Go to original source... Go to PubMed...
  57. Kirchherr H, Kuhn-Velten WN. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B 2006;843(1):100-13. Go to original source...
  58. Choong E, Rudaz S, Kottelat A, Guillarme D, Veuthey JL, Eap CB. Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS. J Pharm Biomed Anal 2009;50(5):1000-8. Go to original source... Go to PubMed...
  59. Hasselstrom J. Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry. J Chromatogr B 2011;879(1):123-8. Go to original source...
  60. Vecchione G, Casetta B, Chiapparino A, Bertolino A, Tomaiuolo M, Cappucci F, Gatta R, Margaglione M, Grandone E. A reliable and rapid tool for plasma quantification of 18 psychotropic drugs by ESI tandem mass spectrometry. J Pharm Biomed Anal 2012;67-68:104-13. Go to original source... Go to PubMed...
  61. Sampedro MC, Unceta N, Gomez-Caballero A, Callado LF, Morentin B, Goicolea MA, Meana JJ, Barrio RJ. Screening and quantification of antipsychotic drugs in human brain tissue by liquid chromatography-tandem mass spectrometry: Application to postmortem diagnostics of forensic interest. Forensic Science International 2012;219(1-3):172-80. Go to original source... Go to PubMed...
  62. Fisher DS, Partridge SJ, Handley SA, Couchman L, Morgan PE, Flanagan RJ. LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Sci Int 2013;229(1-3):145-50. Go to original source... Go to PubMed...
  63. Ansermot N, Brawand-Amey M, Kottelat A, Eap CB. Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring. J Chromatogr A 2013;1292:160-72. Go to original source... Go to PubMed...
  64. Patteet L, Maudens KE, Sabbe B, Morrens M, De Doncker M, Neels H. High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2014;429(0):51-8. Go to original source... Go to PubMed...
  65. Steuer AE, Poetzsch M, Koenig M, Tingelhoff E, Staeheli SN, Roemmelt AT, Kraemer T. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood. J Chromatogr A 2015;1381(0):87-100. Go to original source... Go to PubMed...
  66. Koo TS, Kim SJ, Lee J, Ha DJ, Baek M, Moon H. Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry. Biomed Chromatogr 2011;25(12):1389-94. Go to original source... Go to PubMed...
  67. Misl'anova C, Hutta M. Role of biological matrices during the analysis of chiral drugs by liquid chromatography. J Chromatogr B 2003;797(1-2):91-109. Go to original source...
  68. Noh K, Jang YJ, Kwon K, Kim E, Jeong TC, Yun H, Kang W. Quantitative determination of amisulpride in rat plasma by HPLC-MS/MS, Arch. Pharm. Res. (2015);38:63-7. Go to original source... Go to PubMed...
  69. Urinovska R, Brozmanova H, Sistik P, Silhan P, Kacirova I, Lemr K, Grundmann M. Liquid chromatography-tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum. J Chromatogr B 2012;907:101-7. Go to original source...
  70. Williams L, Merriman S, Lodder H, Howells A, Jordan S, Desbrow C, Cleeve M, Calverley R. High throughput extraction of drugs from biological fluids using an improved supported liquid extraction plate. Book of abstract of TIAFT 2006;247-9.
  71. Raikos N, Spagou K, Vlachou M, Pouliopoulos A, Thessalonikeos E, Tsoukali H. Development of a Liquid-Liquid Extraction Procedure for the Analysis of Amphetamine in Biological Specimens by GC-FID. Open Forensic Sci J 2009;2(1):12-5. Go to original source... Go to PubMed...
  72. Chen J, Hsieh Y. Stabilizing drug molecules in biological samples. Ther Drug Monit 2005;27(5):617-24. Go to original source... Go to PubMed...
  73. Bakhtiar R, Majumdar TK. Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry. J Pharm Tox Met 2007;55(3):227-43. Go to original source... Go to PubMed...
  74. Saar E, Gerostamoulos D, Drummer OH, Beyer J. Assessment of the stability of 30 antipsychotic drugs in stored blood specimens. Forensic Sci Int 2012;215(1-3):152-8. Go to original source... Go to PubMed...
  75. Fisher DS, Partridge SJ, Handley SA, Flanagan RJ. Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum. Forensic Sci Int 2013;229(1-3):151-6. Go to original source... Go to PubMed...
  76. Kubo M, Mizooku Y, Hirao Y, Osumi T. Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma. J Chromatogr B 2005;822(1-2):294-9. Go to original source...
  77. Fernandes C, Van Hoeck E, Sandra P, Lancas FM. Determination of fluoxetine in plasma by gas chromatography-mass spectrometry using stir bar sorptive extraction. Anal Chim Acta 2008;614(2):201-7. Go to original source... Go to PubMed...
  78. Ulrich S, Meyer FP, Bogerts B. A capillary gas-liquid chromatographic method for the assay of the neuroleptic drug zotepine in human serum or plasma. J Pharm Biomed Anal 1996;14(4):441-9. Go to original source... Go to PubMed...
  79. Huang HC, Liu CH, Lan TH, Hu TM, Chiu HJ, Wu YC, Tseng YL. Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients. J Chromatogr B 2007;856(1-2):57-61. Go to original source...
  80. Djordjevic Filijovic N, Pavlovic A, Nikolic K, Agbaba D. Validation of an HPLC method for determination of aripiprazole and its impurities in pharmaceuticals. Acta Chromatogr 26(1) (2014):13-28. Go to original source...
  81. Jamalapuram S, Vuppala PK, Abdelazeem AH, McCurdy CR, Avery BA. Ultra-performance liquid chromatography tandem mass spectrometry method for the determination of AZ66, a sigma receptor ligand, in rat plasma and its application to in vivo pharmacokinetics. Biomed Chromatogr 2013;27(8):1034-40. Go to original source... Go to PubMed...
  82. Moreno AM, Navas MJ, Asuero AG. HPLC-DAD determination of CNS-acting drugs in human blood, plasma, and serum. Critical reviews in analytical chemistry / CRC 2014;44(1):68-106. Go to original source... Go to PubMed...
  83. Mitchell CR, Bao Y, Benz NJ, Zhang S. Comparison of the sensitivity of evaporative universal detectors and LC/MS in the HILIC and the reversed-phase HPLC modes. J Chromatogr B 2009;877(32):4133-9. Go to original source...
  84. Ascalone V, Ripamonti M, Malavasi B. Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid-phase extraction and liquid chromatography on a chiral column - Application to pharmacokinetics. J Chromatogr B 1996;676(1):95-105. Go to original source...
  85. Maurer HH. What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? J Chromatogr A 2013;1292:19-24. Go to original source... Go to PubMed...
  86. Brodie RR, Hill HM. Validation issues arising from the new FDA guidance for industry on bioanalytical method validation. Chromatographia 2002;55(1):S91-4. Go to original source...
  87. Bozovic A, Kulasingam V. Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins. Clin Biochem 2013;46(6):444-55. Go to original source... Go to PubMed...
  88. Monge ME, Harris GA, Dwivedi P, Fernandez FM. Mass spectrometry: recent advances in direct open air surface sampling/ionization. Chemical reviews 2013;113(4):2269-308. Go to original source... Go to PubMed...
  89. M WJ, B.C L. Desorption Electrospray Ionization (DESI) Mass Spectrometry: A brief introduction and overview. Current Separations and Drug Development.
  90. Morelato M, Beavis A, Kirkbride P, Roux C. Forensic applications of desorption electrospray ionisation mass spectrometry (DESI-MS). Forensic Sci Int 2013;226(1-3):10-21. Go to original source... Go to PubMed...
  91. Cody BR, Laramee JA, Nilles JM, Durst HP. Direct analysis in real time (DART) Mass spectrometry. JEOL news 2005;40(1):8-12.
  92. Rosting C, Pedersen-Bjergaard S, Hansen SH, Janfelt C. High-throughput analysis of drugs in biological fluids by desorption electrospray ionization mass spectrometry coupled with thin liquid membrane extraction. The Analyst 2013;138(20):5965-72. Go to original source... Go to PubMed...
  93. Yao C, Na N, Huang L, He D, Ouyang J. High-throughput detection of drugs binding to proteins using desorption electrospray ionization mass spectrometry. Analytica Chimica Acta 2013;794:60-6. Go to original source... Go to PubMed...
  94. Novakova L. Challenges in the development of bioanalytical liquid chromatography-mass spectrometry method with emphasis on fast analysis. J Chromatogr A 2013;1292:25-37. Go to original source... Go to PubMed...
  95. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B 2007;852(1-2):22-34. Go to original source...
  96. Chin C, Zhang ZP, Karnes HT. A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine. J Pharm Biomed Anal 2004;35(5):1149-67. Go to original source... Go to PubMed...
  97. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B 2009;877(23):2198-207. Go to original source...
  98. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 2005;38(4):328-34. Go to original source... Go to PubMed...
  99. Gutierrez-Casares JR, Canas F, Rodriguez-Morales A, Hidalgo-Borrajo R, Alonso-Escolano D. Adherence to Treatment and Therapeutic Strategies in Schizophrenic Patients: The ADHERE Study. CNS Spectr 2010;15(5):327-36. Go to PubMed...
  100. Kennedy WK, Jann MW, Kutscher EC. Clinically significant drug interactions with atypical antipsychotics. CNS Drugs 2013;27(12):1021-48. Go to original source... Go to PubMed...
  101. Poirier MF, Canceil O, Bayle F, Millet B, Bourdel MC, Moatti C, Olie JP, Attar-Levy D. Prevalence of smoking in psychiatric patients. Prog Neuro-Psychopharmacol Biol Psychiatry 2002;26(3):529-37. Go to original source... Go to PubMed...
  102. Llorente Fernandez E, Pares L, Ajuria I, Bandres F, Castanyer B, Campos F, Farre C, Pou L, Queralto JM, To-Figueras J. State of the art in therapeutic drug monitoring. Clinical chemistry and laboratory medicine : CCLM / FESCC 2010;48(4):437-46.
  103. Aucella F, Lauriola V, Vecchione G, Tiscia GL, Grandone E. Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant. Journal of Pharmaceutical and Biomedical Analysis 2013;86:123-6. Go to original source... Go to PubMed...
  104. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clinic proceedings 2008;83(1):66-76. Go to original source... Go to PubMed...
  105. Wilhelm A, den Burger JG, Swart E. Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions. Clin Pharmacokinet 2014;53(11):961-73. Go to original source... Go to PubMed...